Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Arup K. Ghose"'
Publikováno v:
ACS Chemical Neuroscience. 8:147-154
At the discovery stage, it is important to understand the drug design concepts for a CNS drug compared to those for a non-CNS drug. Previously, we published on ideal CNS drug property space and defined in detail the physicochemical property distribut
Autor:
Nathan Anderson, Diane E. Gingrich, Arup K. Ghose, Mark S. Albom, Bruce D. Dorsey, Lisa D. Aimone, Elizabeth Bruckheimer, Jason C. Wagner, Matthew A. Curry, Lihui Lu, Jay Friedman, Mark A. Ator, Bruce Ruggeri, Eugen F. Mesaros, Mangeng Cheng, Zeqi Huang, Keith S. Learn, Matthew R. Quail, Thelma S. Angeles, Pawel Dobrzanski, Gregory R. Ott, Sandra V. Fernandez, Joseph G. Lisko, Kevin J. Wells-Knecht, Weihua Wan
Publikováno v:
Journal of medicinal chemistry. 59(16)
Analogues structurally related to anaplastic lymphoma kinase (ALK) inhibitor 1 were optimized for metabolic stability. The results from this endeavor not only led to improved metabolic stability, pharmacokinetic parameters, and in vitro activity agai
Autor:
Henry J. Breslin, Bruce D. Dorsey, Arup K. Ghose, Mangeng Cheng, Mark S. Albom, Kevin J. Wells-Knecht, Weihua Wan, Thelma S. Angeles, R. Curtis Haltiwanger, Brandon M. Lane, Gregory R. Ott
Publikováno v:
Journal of Medicinal Chemistry. 55:449-464
A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.1(3,7).1(9,13)]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, designed to rigidly lock an energy-minimized bioacti
Publikováno v:
ACS Chemical Neuroscience
The central nervous system (CNS) is the major area that is affected by aging. Alzheimer's disease (AD), Parkinson's disease (PD), brain cancer, and stroke are the CNS diseases that will cost trillions of dollars for their treatment. Achievement of ap
Autor:
Mark S. Albom, Bruce D. Dorsey, Joseph G. Lisko, Mangeng Cheng, Bruce Ruggeri, Arup K. Ghose, Eugen F. Mesaros, Weihua Wan, Mark A. Ator, Matthew R. Quail, Zeqi Huang, Diane E. Gingrich, Tho V. Thieu, Gregory J. Wells, Thelma S. Angeles, Gregory R. Ott, Lisa D. Aimone, Lihui Lu
Publikováno v:
Journal of Medicinal Chemistry. 54:6328-6341
A novel 2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazine scaffold has been designed as a new kinase inhibitor platform mimicking the bioactive conformation of the well-known diaminopyrimidine motif. The design, synthesis, and validation of this new py
Autor:
Linda Weinberg, Ted L. Underiner, Mark S. Albom, Craig A. Zificsak, Arup K. Ghose, Renee C. Roemmele, Mangeng Cheng, Karen L. Milkiewicz, Jay P. Theroff, Bruce D. Dorsey, Thelma S. Angeles
Publikováno v:
Bioorganic & Medicinal Chemistry. 18:4351-4362
Dysregulation of the anaplastic lymphoma kinase (ALK) is implicated in a variety of cancers. A series of tetrahydropyrido[2,3-b]pyrazines was constructed as ring-constrained analogs of a known aminopyridine kinase scaffold. Chemistry was developed to
Publikováno v:
Journal of Medicinal Chemistry. 51:5149-5171
toward kinase inhibitor discovery, with the result that several kinase inhibitors have been approved as drugs since 2001. The commercial success of imatinib (N-(4-methyl-3-(4-(pyridin-3yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-l)methyl)b
Publikováno v:
Drug Discovery Today. 11:1107-1114
The modern drug discovery process is steadily becoming more information driven. Structural, physicochemical and ADME-Tox property profiles of reference (successful) ligands, along with structural information of their target proteins, have been extrem
Publikováno v:
Journal of Receptors and Signal Transduction. 21:357-375
Publikováno v:
Perspectives in Drug Discovery and Design. 19:85-98
Methods for the calculation of two properties of interest in drug design, namely free energy of aqueous solvation and lipophilicity (log P), using fragmental methods are reviewed here. Though aqueous solvation free energies are commonly estimated usi